Vishwas Seshadri News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vishwas seshadri. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vishwas Seshadri Today - Breaking & Trending Today

Cantor Fitzgerald Cuts Abeona Therapeutics (NASDAQ:ABEO) Price Target to $21.00

Abeona Therapeutics (NASDAQ:ABEO – Free Report) had its target price cut by Cantor Fitzgerald from $28.00 to $21.00 in a research report released on Thursday, Benzinga reports. They currently have an overweight rating on the biopharmaceutical company’s stock. Separately, StockNews.com lowered shares of Abeona Therapeutics from a hold rating to a sell rating in a […] ....

Vishwas Seshadri , Brendanm Omalley , Schonfeld Strategic Advisors , Jump Financial , Simplex Trading , Cantor Fitzgerald , Securities Exchange Commission , Worth Venture Partners , Abeona Therapeutics Inc , Acadian Asset Management , Abeona Therapeutics , Free Report , Get Free Report , Exchange Commission , Asset Management , Strategic Advisors , Venture Partners , Therapeutics Inc , Abeona Therapeutics Daily ,

Cantor Fitzgerald Cuts Abeona Therapeutics (NASDAQ:ABEO) Price Target to $21.00

Abeona Therapeutics (NASDAQ:ABEO – Get Free Report) had its price objective decreased by equities research analysts at Cantor Fitzgerald from $28.00 to $21.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage currently has an “overweight” rating on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price objective points to a […] ....

Brendanm Omalley , Vishwas Seshadri , Citigroup Inc , Abeona Therapeutics Inc , Schonfeld Strategic Advisors , Abeona Therapeutics Company Profile , Cantor Fitzgerald , Barclays Plc , Securities Exchange Commission , Capital Management , Abeona Therapeutics , Get Free Report , Exchange Commission , Capital Partners , Therapeutics Inc , Abeona Therapeutics Daily ,

Abeona Therapeutics (NASDAQ:ABEO) Price Target Cut to $21.00 by Analysts at Cantor Fitzgerald

Abeona Therapeutics (NASDAQ:ABEO – Get Free Report) had its price objective lowered by analysts at Cantor Fitzgerald from $28.00 to $21.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The firm currently has an “overweight” rating on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price target indicates a potential upside of […] ....

Vishwas Seshadri , Brendanm Omalley , Worth Venture Partners , Abeona Therapeutics Inc , Schonfeld Strategic Advisors , Simplex Trading , Cantor Fitzgerald , Securities Exchange Commission , Jump Financial , Acadian Asset Management , Abeona Therapeutics , Get Free Report , Exchange Commission , Asset Management , Strategic Advisors , Venture Partners , Therapeutics Inc , Abeona Therapeutics Daily ,

Abeona Therapeutics Inc (NASDAQ:ABEO) CEO Purchases $32,000.00 in Stock

Abeona Therapeutics Inc (NASDAQ:ABEO – Get Free Report) CEO Vishwas Seshadri bought 10,000 shares of Abeona Therapeutics stock in a transaction dated Thursday, April 25th. The stock was purchased at an average price of $3.20 per share, for a total transaction of $32,000.00. Following the purchase, the chief executive officer now directly owns 538,260 shares […] ....

Vishwas Seshadri , Cantor Fitzgerald , Abeona Therapeutics Inc , Securities Exchange Commission , Capital Management , Schonfeld Strategic Advisors , Worth Venture Partners , Jump Financial , Get Free Report , Abeona Therapeutics , Exchange Commission , Therapeutics Inc , Venture Partners , Capital Partners , Strategic Advisors , Abeona Therapeutics Daily , Nasdaq Abeo , Insider Trading , Nsider Trades ,

Insider Buying: Abeona Therapeutics Inc (NASDAQ:ABEO) CEO Acquires 10,000 Shares of Stock

Abeona Therapeutics Inc (NASDAQ:ABEO – Get Free Report) CEO Vishwas Seshadri acquired 10,000 shares of the stock in a transaction dated Thursday, April 25th. The shares were bought at an average cost of $3.20 per share, with a total value of $32,000.00. Following the completion of the transaction, the chief executive officer now owns 538,260 […] ....

Vishwas Seshadri , Abeona Therapeutics Inc , Capital Management , Simplex Trading , Barclays Plc , Schonfeld Strategic Advisors , Citigroup Inc , Cantor Fitzgerald , Get Free Report , Abeona Therapeutics , Therapeutics Inc , Abeona Therapeutics Daily , Nasdaq Abeo , Insider Trading , Nsider Trades ,